KRM Ayurveda IPO Lists at Strong 28% Premium on NSE SME

Shares of KRM Ayurveda Ltd. made an impressive debut on the NSE SME platform, delivering significant gains for IPO investors. The stock opened well above its issue price, reflecting strong market demand and investor confidence on listing day.

Key Listing Highlights

• The shares opened at ₹172.10 per share on 29 January 2026, a 28% premium over the IPO issue price of ₹135.
• This strong debut rewarded IPO allottees with immediate listing gains, making it one of the more successful SME IPO listings recently.

IPO Subscription and Allotment Recap

• The IPO was open for subscription from 21 January to 23 January 2026.
• Final allotment was completed on 27 January 2026.
• KRM Ayurveda’s IPO saw robust demand, with an overall subscription of 74.27 times.
  • Retail investors: subscribed 54.21 times
  • Qualified Institutional Buyers (QIBs): subscribed 63.31 times
  • Non-Institutional Investors: subscribed 135.37 times
    

Issue and Use of Proceeds

• The SME IPO was entirely a fresh issue of 57.40 lakh shares, raising ₹77.49 crore.
• Funds from the issue will be used for:
  • Expanding telemedicine infrastructure
  • Upgrading technology systems
  • Repayment of borrowings
  • Meeting working capital requirements
  • General corporate purposes
  

Market Response and Sentiment

• The performance on listing day suggests solid investor interest in the company’s business model and growth prospects.
• Ahead of listing, the grey market premium (GMP) had indicated healthy sentiment, aligning with the strong debut.

About the Company
KRM Ayurveda operates a network of Ayurvedic hospitals and clinics, offers telemedicine services, and is involved in the manufacture and sale of Ayurvedic and herbal products. As of 31 December 2025, the company had 6 hospitals, 5 clinics, and 443 employees.